Mirus Bio reagents enable high efficiency transfection of stem cells and other hard to transfect cell types used for stem cell research.
Poster presented at the Cellular Dynamics International User Group Meeting: High Efficiency Transfection of iCell® Cardiomyocytes and Stem Cell Relevant Cell Sources (PDF)
Ideal Entry Points for Transfection in Stem Cell Workflow. Somatic cells such as adult fibroblast cells can be transfected or transduced via several methods (e.g. recombinant virus, plasmid, protein, mRNA, small molecule and miRNA) with a combination of transcription factors including KLF4, SOX2, c-Myc, Nanog, Oct-3/4 and LIN-28 to reprogram the cells to a pluripotent state. iPS cells can then be differentiated to a myriad of cell types through growth factor addition and/or transfection of selection markers driven by cell type specific promoters. Stem cell derived cell types such as cardiomyocytes, adipocytes, neural cells, pancreatic-β cells, and hematopoietic progenitor cells can provide researchers with relevant models for their experiments.
Efficient Genome Editing with Cas9 + Guide RNA Ribonucleoprotein Complexes. TransIT-X2® Dynamic Delivery System was used to deliver Cas9 protein/guide RNA ribonucleoprotein (RNP) complexes in human induced pluripotent stem cells (iPSCs). A T7E1 mismatch assay was used to measure cleavage efficiency at 48 hours post-transfection.
Cell Type | Nucleic Acid | Mirus Reagent(s) Used | Application | Reference |
---|---|---|---|---|
Human embryonic stem cell derived neural progenitors | Plasmid DNA | TransIT®-2020 | Stem cell transfection | Scientist feedback |
Human foreskin fibroblasts | Plasmid DNA | TransIT®-2020 | DNA transfection | Scientist feedback |
Human induced pluripotent stem (iPS) cells | Plasmid DNA | TransIT®-2020 | Stem cell transfection | Data |
Plasmid DNA | Ingenio® | Stem cell transfection | Data | |
RNP | TransIT-X2® | Genome Editing | Data | |
Human mesenchymal stem cells | Plasmid DNA | TransIT®-2020 | Stem cell transfection | Scientist feedback |
Human skin fibroblasts | Plasmid DNA | TransIT®-2020 | DNA transfection | Scientist feedback |
iCell® Cardiomyocytes | Plasmid DNA | TransIT®-LT1 | Stem cell transfection | Data |
Mouse embryonic fibroblasts | Plasmid DNA | TransIT®-2020 | DNA transfection | Scientist feedback |
Mouse embryonic stem cell derived cardiomyocytes | Plasmid DNA | TransIT®-2020 | Stem cell transfection | Scientist feedback |
Normal human dermal fibroblasts (NHDF) | Plasmid DNA | TransIT®-2020 | DNA transfection | Scientist feedback |
SRF -/- mouse embryonic stem cells | Plasmid DNA | TransIT®-LT1 | Stem cell transfection | Citation |
BJ human neonatal foreskin fibroblasts | mRNA | TransIT®-mRNA | Stem cell reprogramming | Citation |
C3H/10T1/2 | mRNA | TransIT®-mRNA | Stem cell reprogramming | Citation |
CCD-1109Sk human normal adult skin fibroblasts | mRNA | TransIT®-mRNA | Stem cell reprogramming | Citation |
MRC-5 human lung fibroblasts | mRNA | TransIT®-mRNA | Stem cell reprogramming | Citation |
Primary human neonatal epidermal keratinocytes | mRNA | TransIT®-mRNA | Stem cell reprogramming | Citation |
Primary human lung fibroblasts | mRNA | TransIT®-mRNA | Stem cell reprogramming | Citation |
Human mesenchymal stem cells | siRNA | TransIT-TKO® | Stem cell differentiation | Citation |
iCell® Cardiomyocytes | siRNA | TransIT-TKO® | Knockdown of gene expression | Data |
Human adipose derived adult stem cells (hADAS) | siRNA | TransIT-siQUEST® | Knockdown of gene expression | Citation |
Download Protocol: Reverse Transfection of Human Induced Pluripotent Stem (iPS) Cells with TransIT®-LT1 Transfection Reagent (PDF)
Exceptional Transfection Efficiency in Human Induced Pluripotent Stem Cells (iPSCs) via Reverse Transfection with TransIT®-LT1. The TransIT®-LT1 Transfection Reagent was used to reverse transfect 1.3 x 106 iPS cells with a ZsGreen expressing plasmid (Clontech). Reverse transfections were performed in 6-well plates using 12 µl of TransIT®-LT1 Transfection Reagent to deliver 4 µg of DNA (3:1, reagent: DNA). Cells were visualized 48 hours post-transfection and imaged under a 10X objective with an Olympus IX71® Inverted Microscope. Images are (A) phase contrast and (B) green fluorescence. Cells were assayed 48 hours post-transfection on an Accuri® Cytometer. The histogram (C) shows untransfected cells (black line) compared to cells transfected with plasmid using TransIT®-LT1 (green line). See more information on stem cell applications.
High Efficiency of Gene Expression in Mouse Embryonic Stem Cells (mESCs) using TransIT®-LT1. Mouse Embryonic Stem Cells (mESCs) were seeded at 250,000 cells per well of a 6-well plate and transfected two hours after plating with 6 μl of TransIT®-LT1 Transfection Reagent and 2.5 μg of a GFP expressing plasmid. Efficiency of transfection was visualized at approximately 60%. Images were taken using a Leica DMI 6000B inverted microscope 48 hours post-transfection. Images are (A) phase contrast, (B) green fluorescence, and (C) merged field.
Plasmid DNA Delivery to iCell® Cardiomyocytes Using TransIT®-LT1 Transfection Reagent. (A) High efficiency transfection of iCell® Cardiomyocytes with a GFP encoding plasmid. iCell® Cardiomyocytes were plated at 20,000 cells/well in a 96 well tissue culture plate coated with 0.1% gelatin. After allowing the cells to recover from thaw, cells were transfected with 100 ng/well of pMAXGFP (Lonza) using TransIT®-LT1 Transfection Reagent with a 2:1 reagent-to-DNA ratio according to the manufacturer’s instructions. Fluorescent images were taken 3 days post transfection using a Olympus IX71® inverted microscope. (B) cAmp induction measured via a luciferase reporter plasmid. iCell® Cardiomyocytes were plated for 5 days and subsequently replated using 40,000 or 80,000 cells/well in a 96 well plate pre-coated with gelatin. Three days post-replating cells were transfected using TransIT®-LT1 and a CRE-luciferase reporter plasmid. After 18 hours the cAMP pathway was induced using 10 µM isoproterenol for 6 hours. Luciferase activity was measured using the Promega Dual Glo® Luciferase Assay. Data is normalized to the control reporter.
Data courtesy of
Cell Type | Nucleic Acid | Mirus Reagent(s) Used | Application | Reference |
---|---|---|---|---|
Human embryonic stem cell derived neural progenitors | Plasmid DNA | TransIT®-2020 | Stem cell transfection | Scientist feedback |
Human foreskin fibroblasts | Plasmid DNA | TransIT®-2020 | DNA transfection | Scientist feedback |
Human induced pluripotent stem (iPS) cells | Plasmid DNA | TransIT®-2020 | Stem cell transfection | Data |
Plasmid DNA | Ingenio® | Stem cell transfection | Data | |
Human mesenchymal stem cells | Plasmid DNA | TransIT®-2020 | Stem cell transfection | Scientist feedback |
Human skin fibroblasts | Plasmid DNA | TransIT®-2020 | DNA transfection | Scientist feedback |
iCell® Cardiomyocytes | Plasmid DNA | TransIT®-LT1 | Stem cell transfection | Data |
Mouse embryonic fibroblasts | Plasmid DNA | TransIT®-2020 | DNA transfection | Scientist feedback |
Mouse embryonic stem cell derived cardiomyocytes | Plasmid DNA | TransIT®-2020 | Stem cell transfection | Scientist feedback |
Normal human dermal fibroblasts (NHDF) | Plasmid DNA | TransIT®-2020 | DNA transfection | Scientist feedback |
SRF -/- mouse embryonic stem cells | Plasmid DNA | TransIT®-LT1 | Stem cell transfection | Citation |
TransIT®-mRNA Transfection Kit yields Higher Efficiency and Cell Viability following 14 Consecutive Transfections Compared to Lipofectamine® RNAiMAX and Stemfect™ RNA Transfection Kit. Experimental details on repeated transfections are described above. Transfection efficiency was measured by flow cytometry on a Guava® easyCyte™ 5HT following 14 consecutive daily transfections (blue bars). Cell viability was determined using cell counts measured during flow cytometry (black line grey bars). Error bars represent the standard deviation of triplicate wells.
Plasmid DNA Electroporation of Human Induced Pluripotent Stem (iPS) Cells with Ingenio®. The Ingenio® Electroporation Kit was used to transfect 2 x 106 iPS cells on the Amaxa® Nucleofector® II Device. Cells were electroporated with 8 µg ZsGreen expressing plasmid (Clontech) in 100 µl and plated in 6-well plates at 0.33 x 106 cells/well. Cells were visualized 24 hours post-transfection and imaged under 4X objective with an Olympus IX71® Inverted Microscope. Images are (A) phase contrast, and (B) green fluorescence. Cells were also assayed 24 hours post-transfection on an Accuri® Cytometer. The histogram (C) shows unelectroporated cells (black line) compared to cells electroporated with plasmid using the Ingenio® Electroporation Kit (green line).
Data courtesy of
Product | Shelf Life | Cost/Electroporationb | Savings |
---|---|---|---|
Amaxa® Nucleofector® Kit V (VCA-1003) | 3 months | $14.64 | – |
Ingenio® Electroporation Kit (MIR 50112) | 1 year | $8.68 | 41% |
a Compatible with Amaxa® Nucleofector® II device
b Based on 2014 U.S. List prices from company websites and protocol recommendations (25 RXN kit).
An advanced system for delivery of CRISPR/Cas9 components in human IPSCs
A high performance, animal-free, broad spectrum DNA transfection reagent
A low toxicity, broad spectrum DNA transfection reagent
A high efficiency, low toxicity transfection reagent for large RNA delivery
High efficiency electroporation using any instrument
Don’t See Your Cell Type? Consult Reagent Agent® Transfection Database
Citation Database: Check if our reagents have been used by other researchers to transfect your cell type
Technical Support: Speak directly with a transfection expert